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Abstract
Rationale Previous studies have shown that orexin-1/hypo-
cretin-1 receptors play a role in self-administration and cue-
induced reinstatement of food, drug, and ethanol seeking. In
the current study, we examined the role of orexin-1/hypo-
cretin-1receptorsinoperantself-administrationofethanoland
sucrose and in yohimbine-induced reinstatement of ethanol
and sucrose seeking.
Materials and methods Rats were trained to self-administer
either 10% ethanol or 5% sucrose (30 min/day). The orexin-1
receptor antagonist SB334867 (0, 5, 10, 15, 20 mg/kg, i.p.)
was administered 30 min before the operant self-administra-
tion sessions. After these experiments, the operant self-
administration behaviors were extinguished in both the
ethanol and sucrose-trained rats. Upon reaching extinction
criteria, SB334867 (0, 5, 10 mg/kg, i.p.) was administered
30 min before yohimbine (0 or 2 mg/kg, i.p.). In a separate
experiment, the effect of SB334867 (0, 15, or 20 mg/kg, i.p.)
on general locomotor activity was determined using the open-
field test.
Results The orexin-1 receptor antagonist, SB334867 (10, 15
and 20 mg/kg) decreased operant self-administration of 10%
ethanol but not 5% sucrose self-administration. Furthermore,
SB334867 (5 and 10 mg/kg) significantly decreased yohim-
bine-induced reinstatement of both ethanol and sucrose
seeking. SB334867 did not significantly affect locomotor
activity measured using the open-field test.
Conclusions The results suggest that inhibition of OX-1/
Hcrt-1 receptors modulates operant ethanol self-administra-
tion and also plays a significant role in yohimbine-induced
reinstatement of both ethanol and sucrose seeking in rats.
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Introduction
The orexins (or hypocretins) are neuropeptides produced
exclusively in the lateral hypothalamus (de Lecea etal. 1998;
Peyron et al. 1998; Sakurai et al. 1998), an area activated
by consummatory rewards (Bernardis and Bellinger 1996;
Levitt and Teitelbaum 1975) and strongly linked to
preferences for cues associated with food and drug reward
(Harris et al. 2005). Orexin/hypocretin-containing neurons
have widespread projections throughout the central nervous
system (CNS; Nambu et al. 1999; Peyron et al. 1998).
There are currently two identified orexin/hypocretin pep-
tides, orexin-A/hypocretin-1 and orexin-B/hypocretin-2,
and two orexin/hypocretin receptors, the orexin-1/hypocre-
tin-1 (OX-1/Hcrt-1) receptor and the orexin-2/hypocretin-2
(OX-2/Hcrt-2) receptor (de Lecea et al. 1998; Sakurai et al.
1998). The OX-1/Hcrt-1 receptor is selective for orexin-A/
hypocretin-1, while the OX-2/Hcrt-2 receptor is nonselec-
tive for both orexin-A/hypocretin-1 and orexin-B/hypocre-
tin-2 (Sakurai et al. 1998). Although both receptors are
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e-mail: selenab@gallo.ucsf.eduexpressed throughout the CNS, the ventral tegmental area
(VTA) and locus coeruleus (LC) exhibit the highest
expression levels (Sakurai 2007). Furthermore, the locus
coeruleus, a key modulator of attentional state, has been
shown to receive the densest innervation of orexin/
hypocretin neurons (Hagan et al. 1999; Horvath et al.
1999). The orexin/hypocretin system was initially implicat-
ed in the regulation of homeostatic functions such as
feeding and arousal (Hagan et al. 1999; Mignot 2001;
Sakurai et al. 1998; Sutcliffe and de Lecea 2002; Willie et
al. 2001). However, results from more recent studies
indicate that orexins/hypocretins play a significant role in
reward-related behaviors (Borgland et al. 2006; Boutrel
2006; DiLeone et al. 2003; Harris and Aston-Jones 2006;
Harris et al. 2005; Lawrence et al. 2006; Narita et al. 2006).
Relapse to drug seeking is a hallmark of addictive
behaviors, yet there are currently few effective treatments
for preventing relapse after a protracted period of absti-
nence. A number of methods have been developed in
animals to study reinstatement of drug seeking and have
adequate validity to model aspects of relapse in humans
(Epstein et al. 2006, no. 16). For example, reinstatement of
drug seeking in laboratory animals is induced by environ-
mental cues and contexts associated with drug availability,
reexposure to the drug itself, and stress. These conditions
have been reported to induce relapse to drug taking in
humans (Epstein et al. 2006; Katz and Higgins 2003;
Spanagel 2003). The orexin/hypocretin system has been
shown to play a key role in cue-induced reinstatement of
morphine, nicotine, and ethanol seeking (DiLeone et al.
2003; Lawrence et al. 2006; Narita et al. 2006; Pasumarthi
et al. 2006) and has been proposed to play a role in
footshock stress-induced reinstatement of cocaine seeking
(Boutrel et al. 2005); however, the role of the orexin/
hypocretin system in stress- or yohimbine-induced rein-
statement of ethanol seeking is not known.
It has been shown that yohimbine, an α-2 adrenoceptor
antagonist, induces a stress-like state in both humans and
laboratory animals (Bremner et al. 1996a, b; Vythilingam et
al. 2000). In contrast to other stressors, yohimbine activates
c-fos and CRF mRNA in the same brain regions as that
elicited after footshock-induced stress (Funk et al. 2006).
Furthermore, the brain areas activated by yohimbine and
footshock were found to be regionally specific in brain
regions associated with the rewarding effects of ethanol and
other substances of abuse, notably, the shell of the nucleus
accumbens, basolateral and central amygdalar nuclei, and
the bed nucleus of the stria terminalis (Funk et al. 2006).
Footshock-induced stress has been shown to be effective in
inducing reinstatement of cocaine, heroin, ethanol, and
nicotine seeking (Buczek et al. 1999; Erb et al. 1996; Funk
et al. 2006; Le et al. 2000; Le et al. 1998; Liu and Weiss
2002; Lu et al. 2003; Shaham et al. 1997); however, its
ability to reinstate seeking of natural rewards such as
sucrose has been inconsistent (Buczek et al. 1999). Based
on the neurochemical data and the increasing evidence
showing that yohimbine reinstates reward-seeking behavior
(Funk et al. 2006; Gass and Olive 2007; Ghitza et al. 2006;
Le et al. 2005; Lee et al. 2004; Marinelli et al. 2007; Nair et
al. 2006; Shepard et al. 2004), we used yohimbine in the
current study to induce reinstatement to determine the role
of the OX-1/Hcrt-1 receptors in the reinstatement of ethanol
and sucrose seeking.
Materials and methods
Subjects
Male Long–Evans rats weighing 180–200 g upon arrival
(Harlan Indianapolis, IN, USA), were individually housed
in ventilated Plexiglas cages in a climate-controlled room
on a 12-h light–dark cycle (lights on at 7 A.M.). Operant
training occurred between 8 A.M. and 12 P.M., Monday
through Friday. Food and water were available ad libitum,
except for short periods during initial self-administration
training, as outlined below. All procedures were preap-
proved by the Gallo Center Institutional Animal Care and
Use Committee and were in accordance with NIH guide-
lines for the Humane Care and Use of Laboratory Animals.
Drugs
SB334867 (1-(2-methylbenzoxazol-6-yl)-3-[1,5]naphthydrin-
4-yl urea HCl; Tocris, MI, USA) was made up in a vehicle
solution containing saline with 25% cyclodextrin (w/v)a n d
5% dimethyl sulfoxide (v/v) and was administered at doses of
5, 10, 15, or 20 mg/kg (as outlined in the methods for each
experiment). Yohimbine (Sigma Aldrich, MO, USA) was
made up in distilled water and administered at a dose of
2 mg/kg, in accordance with previous reinstatement studies
(Gass and Olive 2007;G h i t z ae ta l .2006;L ee ta l .2005;
Marinelli et al. 2007;N a i re ta l .2006; Shepard et al. 2004).
Vehicle injections were administered in the same volume as
the injected drug as a control condition. Sucrose solutions [5
or 10% sucrose (w/v) Fisher Scientific, NJ, USA] were pre-
pared using filtered water. The 10% ethanol (v/v) solution was
prepared using 95% ethyl alcohol (Gold Shield Chemical,
Hayward, CA DSP-CA-151, USA) and filtered water. In the
sucrose fade experiments, 10%, 5%, 3%, and 1% sucrose,
respectively, were dissolved in 10% ethanol (w/v).
Apparatus
Self-administration testing was conducted in standard
operant conditioning chambers (Coulbourn Instruments,
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cles with a fan for ventilation and background white noise.
Each operant conditioning chamber housed two retractable
levers on the right wall (4 cm above the grid floor, 12 cm
apart). A liquid dipper system was placed centrally between
the two levers. A house light was present on the wall
opposite the levers and remained on at all times during the
operant conditioning session. Stimulus lights were present
2 cm above each lever. An apparatus to emit a tone under
specific conditions for operant responding was also present.
Upon correct (active) lever press(es), the stimulus light
above the active lever was illuminated and accompanied by
a tone for 3 s to indicate availability of reward in the dipper
receptacle. The dipper port was illuminated for 10 s, while
the dipper cup was available. If the cup was not actively
licked during the 10 s, the cup fell, and this event was
recorded as a null response. For the cup to be available
again, the rat had to perform another fixed ratio. The
number of reinforcers obtained per operant self-administra-
tion sessions was determined as the total number of
reinforcers offered minus the null responses. Stimulus,
fluid delivery, and operant responses were all controlled
and recorded by computer (Coulbourn Instruments, Allen-
town, PA, USA) using Graphic State 2.0 software. Inactive
lever presses were also recorded as a measure of general
activity but had no programmed consequences.
Operant self-administration procedure
Before beginning the operant self-administration training,
rats were exposed to 10% ethanol or 5% sucrose solution
(depending on which test group they were assigned) as the
only liquid source in their home cages for 3 days. Rats were
then fluid restricted for 22 h before being placed in the
operant conditioning chambers for a 14-h overnight session
on an FR1 schedule of reinforcement (0.1 ml after a single
lever press) with either 10% or 5% sucrose as the reinforcer
for the ethanol and sucrose assigned group, respectively.
During this phase, only the active lever was available for the
rat to press, to facilitate learning. Initial daily training
consisted of 45 min FR1 operant conditioning sessions and
2-h daily water access, with water access immediately after
the training sessions. Once conditions for operant responding
were established (2–4 days), rats were given free access to
water in the home cage and continued on a 45-min FR1
schedule for 3–4 days. Subsequently, operant conditioning
training sessions were reduced to 30 min, and the work ratio
increased to an FR3 schedule of reinforcement (three active
lever presses required for 0.1 ml reward). A second, inactive
lever was also introduced at this time. Upon pressing the
inactive lever, no reinforcer, cue light, or auditory stimuli
were presented, and the event was merely recorded as a
measure of nonspecific behavioral activation. For rats
assigned to the 10% ethanol group, a sucrose fading
technique began at this point, and 10% ethanol was added
to the sucrose solution (Samson 1986). Throughout the next
eight to ten operant conditioning sessions, the sucrose
concentration was gradually decreased (5%, 3%, and 1%)
until the rats responded on an FR3 schedule for 10% ethanol
alone. Stable baseline responding was achieved when the
number of responses for each rat varied within 20% of the
average for the group over three consecutive sessions. Both
ethanol and sucrose groups had reached stable baseline
responding at the FR3 level after 20 sessions.
Experiment 1—effect of SB334867 on operant
self-administration of ethanol and sucrose
Rats were trained to self-administer either 10% ethanol or 5%
sucrose in operant conditioning chambers as outlined above.
Once the rats had achieved stable baseline responding levels,
they were tested once per week with SB334867 (5, 10, 15,
20 mg/kg i.p.) or vehicle. Drug (or vehicle) was administered
30minbeforethestartoftheoperantconditioningsession.All
ethanol self-administering rats received all drug doses and
vehicle conditions in a counterbalanced, Latin square design.
In sucrose self-administering rats, initial indications showed
no effect of SB334867 at 20 mg/kg, so rats were only tested
with this dose or vehicle. Regular 30 min operant self-
administration sessions were run on days between test
sessions.
Experiment 2—effect of SB334867 on general locomotor
activity
Testing was conducted using 40×40 cm open-field loco-
motor activity-monitoring chambers equipped with hori-
zontal photobeams (Med Associates, St Albans, VT, USA).
Horizontal locomotor activity was monitored at 100 ms,
and stereotypic behaviors were also recorded throughout
the session. Locomotor studies were run in daily 2 h
sessions over four consecutive days. On day 1, rats were
placed into the activity chamber for 2 h, no data were
collected, and this session was used solely for habituation
purposes. On days 2 and 3, animals were placed into the
activity chamber, and the session was paused after 60 min,
while animals were removed from the chamber and given a
single i.p. injection of saline (3 ml/kg) to habituate animals
to the injection procedure before the test day. Animals were
returned to the activity chambers and the session continued
for an additional 60 min. Data from the third day was used
to assign animals to one of three treatment groups (0, 15,
20 mg/kg SB334867), six animals per group. On day 4, the
animals were once again placed in the activity chambers,
and the session was paused after 60 min, while the animals
received a single i.p. injection of either vehicle or drug,
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the activity chamber immediately after the injections, and
the session continued for an additional 60 min, drug
challenge. At the end of each session, animals were
returned to the home cage. Data were collected across the
entire 2 h (120 min) session and recorded as distance
traveled in centimeters and total number of stereotypic
counts. Data were separated into habituation (0–60 min)
and drug challenge (60–120 min) for statistical analysis.
Data analysis was performed by one-way analysis of
variance (ANOVA) using the between subjects factor of
treatment (SB334867 dose).
Experiment 3—effect of SB334867 on yohimbine-induced
reinstatement
For the reinstatement study, ethanol- or sucrose-seeking
behavior was extinguished in rats trained to self-administer
10% ethanol or 5% sucrose, respectively, under FR3
conditions. During the extinction training, lever pressing
on the active lever resulted in light and tone cue
presentation but no reward delivery. Neither 10% ethanol
nor 5% sucrose was available throughout extinction
training. Extinction training continued until the rats
responded with less than ten active lever presses per
session or less than 10% of their previous baseline pressing
on the active lever for two consecutive sessions (Fig. 2).
The rats were assigned to one of six groups (three ethanol
groups and three sucrose groups), matched for their
previous operant self-administration responding. We used
the between subjects factor of SB334867 dose (0, 5, 10
mg/kg i.p.) and the within subjects factor of yohimbine dose (0,
2 mg/kg, i.p.) to assess the effect of SB334867 on
yohimbine-induced reinstatement. Animals received two
injections per test day as outlined in Table 1. On test days,
the rats were first injected with either SB334867 or its
vehicle and 30 min later with either yohimbine or the
yohimbine vehicle. Rats were placed into the operant self-
administration chambers 30 min after the second injection
for the 30-min-long reinstatement test session. Reinstate-
ment sessions were run under the same conditions as the
extinction sessions; successful FR3 responses at the
previously active lever resulted in light and tone cue
presentation with no reward delivery. Again, inactive lever
responding had no programmed consequences and was
used as a measure of nonspecific behavioral activation. Rats
were tested with vehicle and yohimbine consecutively over
two test sessions, 7 days apart. Regular 30-min extinction
sessions were run on the between-test days.
Statistics
The data from the ethanol and sucrose groups in the operant
self-administration and reinstatement experiments were
analyzed separately. The data from the operant self-
administration studies were analyzed by repeated measures
two-way ANOVA using the within-subjects factors of
SB334867 dose and lever. The data from the reinstatement
studies were analyzed by two-way ANOVA using the
between subjects factor of SB334867 dose and within
subjects factors of yohimbine dose. Active and inactive
lever data were analyzed separately, as there was no effect
of either SB334867 or yohimbine on inactive lever pressing
and therefore no need for determination of any drug × lever
interactions. For the locomotor activity study, drug chal-
lenge (60–120 min) data were analyzed by one-way
ANOVA using the between subjects factor of SB334867
dose. All statistical analyses were performed using Sigma-
Stat software, and in all cases, post hoc analysis was
determined by Student Newman–Keuls test where overall
significance was p<0.05.
Results
Experiment 1: effect of SB334867 on operant self-
administration of ethanol and sucrose
SB334867 significantly attenuated operant self-administra-
tion of 10% ethanol in a dose-dependent manner compared
Table 1 Injection procedure for reinstatement control and test sessions
Week 1 (controls) Week 2 (reinstatement test)
Injection 1 Injection 2 Injection 1 Injection 2
Group 1 Vehicle SB334867 Vehicle Yohimbine Vehicle SB334867 2 mg/kg Yohimbine
Group 2 5 mg/kg SB334867 Vehicle Yohimbine 5 mg/kg SB334867 2 mg/kg Yohimbine
Group 3 10 mg/kg SB334867 Vehicle Yohimbine 10 mg/kg SB334867 2 mg/kg Yohimbine
Ethanol (three groups) and sucrose (three groups) trained rats were tested over 2 weeks. The control injections (week 1) determined any effect of
SB334867 on extinction baseline responding. Reinstatement (week 2) determined any effect of SB334867 on yohimbine-induced reinstatement of
ethanol or sucrose seeking. Injections were administered i.p. 30 min apart. The second injection (yohimbine vehicle or yohimbine) was given
30 min before the start of the operant session
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two-way ANOVA of lever pressing revealed a significant
effect of SB334867 dose (F[4,69]=4.4, p<0.01, Fig. 1a), a
significant effect of lever (F[1,69]=31.7, p<0.001), and a
significant interaction of SB334867 dose × lever (F[4,69]=
4.5, p<0.01). Post hoc analysis further revealed that the
SB334867 dose had no effect on inactive lever pressing
(Table 2). One-way ANOVA analysis of number of
reinforcers obtained also revealed an overall main effect of
the SB334867 dose (F[4,38]=3.0, p<0.05). Post hoc
analyses revealed that 10, 15, and 20 mg/kg doses
significantly reduced the number of reinforcers obtained
compared to vehicle (Fig. 1b). In contrast, SB334867
(20 mg/kg) did not affect 5% sucrose operant self-adminis-
tration when compared to vehicle-treated animals (data not
shown). Repeated measures two-way ANOVA of lever
pressing revealed a significant effect of lever (F[1,31]=
169.5, p<0.001), but nonsignificant effect of SB334867
dose, and no interaction of SB334867 dose × lever (data not
shown). Furthermore, one-way ANOVA of the number of
sucrose reinforcers also showed a nonsignificant effect of
SB334867 dose (data not shown).
Experiment 2: effect of SB334867 on general locomotor
activity
There was no statistical difference in baseline general
locomotor activity between treatment or vehicle groups
during the 1-h habituation period. Furthermore, there was
no overall main effect on the general locomotor activity
during the 1-h drug challenge period that followed
immediately after the SB334867 (15 or 20 mg/kg) or
vehicle injection. One-way ANOVA of data during the drug
challenge period revealed no effect of SB334867 on either
total distance traveled or total number of stereotypic counts
(data not shown).
Experiment 3: effect of SB334867 on yohimbine-induced
reinstatement of ethanol and sucrose seeking
Ethanol and sucrose self-administering animals extinguished
their lever pressing behavior at similar rates, requiring
approximately 4 weeks to reach extinction criteria (Fig. 2).
After extinction of the ethanol-seeking behavior, yohimbine
(2 mg/kg, i.p.) induced reinstatement of lever responding on
the active lever that had previously been associated with
ethanol reinforcement. Two-way ANOVA analysis of active
lever responding in ethanol-experienced rats revealed a
significant interaction of yohimbine dose × SB334867 dose
(F(2,57)=5.8, p<0.01). Post hoc analysis further revealed
that yohimbine, in the absence of SB334867, significantly
increased active lever responding (p<0.001, Fig. 3). Fur-
thermore, the reinstatement was inhibited by pretreatment
with SB334867 (5 and 10 mg/kg), as both doses tested
significantly attenuated yohimbine-induced reinstatement of
active lever responding (Fig. 3).
In accordance with the ethanol data, two-way ANOVA
analysis of active lever responding in sucrose-experienced
rats revealed a significant effect of the yohimbine dose
(F[1, 39]=5.0, p<0.05) and a significant interaction of the
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Fig. 1 Effect of SB334867 on operant self-administration of 10%
ethanol. a Mean±SEM number of active lever presses. b Mean±SEM
number of ethanol reinforcers obtained. Rats were pretreated with
SB334867 or its vehicle 30 min before the 30-min self-administration
sessions (n=8–9 per group). *p<0.05; **p<0.01; ***p<0.001
compared to vehicle condition
Table 2 Effect of SB334867 on inactive lever pressing in operant
self-administration of ethanol
SB334867 (mg/kg)
Vehicle 5 10 15 20
0±0 1±1 2±1 2±1 3±1
Mean±SEM inactive lever presses. Rats were pretreated with
SB334867 or its vehicle 30 min before the 30-min ethanol self-
administration sessions (n=8–9 per group)
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Post hoc analysis further revealed that yohimbine, in the
absence of SB334867, significantly increased active lever
responding (p<0.001, Fig. 4). Furthermore, SB334867
significantly attenuated yohimbine-induced reinstatement
of active lever responding at both doses tested (Fig. 4).
After extinction of the ethanol- and sucrose-seeking
behavior, SB334867 alone, in the absence of yohimbine,
had no effect on active lever responding compared to
vehicle in either ethanol- or sucrose-experienced rats
(Figs. 3 and 4, respectively). Inactive lever responses were
unaffected by any treatment in both ethanol- and sucrose-
experienced rats (Table 3).
Discussion
The present study shows that the OX-1/Hcrt-1 receptor
antagonist, SB334867, dose dependently attenuates operant
self-administration of ethanol, but not sucrose. After
extinction of the ethanol- and sucrose-seeking behavior,
we found that yohimbine induced a robust reinstatement of
both ethanol and sucrose seeking that was significantly
attenuated by SB334867 in both the ethanol- and sucrose-
experienced rats.
Role of OX-1/Hcrt-1 receptors in operant self-
administration of ethanol and sucrose
The OX-1/Hcrt-1 receptor antagonist SB334867 dose
dependently attenuates self-administration of ethanol, but
not sucrose, supporting previous studies demonstrating a
role for OX-1/Hcrt-1 receptors in ethanol self-administra-
tion (Lawrence et al. 2006). The fact that SB334867 only
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Fig. 3 Effect of SB334867 on yohimbine-induced reinstatement of
ethanol seeking. Mean±SEM number of active lever presses during
extinction and reinstatement tests. Extinction is shown as the average
number of lever presses across the two sessions preceding the first
reinstatement test for all rats. Rats were pretreated with SB334867 or
its vehicle 30 min before yohimbine or its vehicle. Yohimbine (or
vehicle) was administered 30 min before the start of the reinstatement
session (n=8–11 per group). †p<0.001 compared to yohimbine-
vehicle condition in rats injected with the SB334867 vehicle (0 dose);
***p≤0.001 compared to SB334867 vehicle condition in rats injected
with yohimbine
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Fig. 2 Operant training and extinction of responding for 10% ethanol
and 5% sucrose. Mean±SEM number of active and inactive lever
presses during the last 5 days of operant training and first 5 days of
extinction training. Last day of extinction training before reinstatement
tests is also shown (day 24)
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Fig. 4 Effect of SB334867 on yohimbine-induced reinstatement of
sucrose seeking. Mean±SEM number of active lever presses during
extinction and reinstatement tests. Extinction is shown as the average
number of lever presses across the two sessions preceding the first
reinstatement test for all rats. Rats were pretreated with SB334867 or
its vehicle 30 min before yohimbine, or its vehicle. Yohimbine (or
vehicle) was administered 30 min before the start of the reinstatement
session (n=6–7, per group). †p<0.001 compared to yohimbine-
vehicle condition in rats injected with the SB334867 vehicle (0 dose);
**p<0.01; ***p<0.001 compared to SB334867 vehicle condition in
rats injected with yohimbine
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exposure to ethanol in combination with the presentation of
the cues that signal ethanol availability leads to an increased
activation of OX-1/Hcrt-1 receptors. This suggestion is
further supported by the studies showing that orexin/
hypocretin neurons are activated by ethanol-associated
stimuli (Dayas et al. 2008). However, the finding that
SB334867 had no effect on sucrose self-administration
suggests that OX-1/Hcrt-1 receptors are not activated by
sucrose or sucrose-associated cues. It remains to be
determined if SB334867 reduced ethanol self-administra-
tion as a result of interference with ethanol-induced
activation of OX-1/Hcrt-1 receptors and or the ethanol-
associated cues.
Role of OX-1/Hcrt-1 receptors in yohimbine-induced
reinstatement of ethanol and sucrose seeking
In the present study, we show that the OX-1/Hcrt-1 receptor
antagonist, SB334867, attenuates yohimbine-induced rein-
statement of ethanol and sucrose seeking. The protocol
developed for studying reinstatement of drug seeking in
animals has been shown to have validity for studying relapse
to drug addiction in humans (Epstein et al. 2006; Katz and
Higgins 2003; Spanagel 2003). Stress and reexposure to
cues or to the context previously associated with drug
availability are common reasons for relapse to drug seeking
in humans and induce reinstatement of drug seeking in
rodents (Liu and Weiss 2003; Shaham et al. 2000; Zironi et
al. 2006). A “stress response” is generally believed to
involve the CRF system and activation of the HPA-axis (for
review see Koob 1999). However, emerging evidence
suggests that the orexin/hypocretin system may also be
involved in the response to stress (Paneda et al. 2005;
Winsky-Sommerer et al. 2005). For example, the orexin/
hypocretin peptides have been shown to induce dose-
dependent activation of the HPA system; an effect that can
be completely prevented using a CRF-1 receptor antagonist
(Jaszberenyi et al. 2000), and recent data suggest that the
CRF system directly innervates orexin/hypocretin express-
ing neurons (Winsky-Sommerer et al. 2005). Furthermore,
SB334867 has been shown to attenuate footshock-induced
reinstatement of cocaine seeking (Boutrel et al. 2005).
Orexin-A/hypocretin-1 has been shown to induce noradren-
aline release (Hirota et al. 2001) and orexin-A/hypocretin-1
induced reinstatement of cocaine seeking has been blocked
using CRF-1 and noradrenergic receptor antagonists (Boutrel
et al. 2005). It is also hypothesized that orexin/hypocretin
neurons and CRF-expressing neurons constitute a feedback
system which regulates arousal in response to stressful
stimuli (Paneda et al. 2005; Winsky-Sommerer et al. 2003;
2005; Winsky-Sommerer et al. 2004).
The exact mechanism underlying yohimbine-induced
reinstatement is still unknown; however, it is plausible to
suggest that yohimbine may induce reinstatement through a
mechanismsimilar tothatoforexin-A/hypocretin-1.Evidence
todirectlysupportthis hypothesiscomes fromthe observation
that orexin-A-/hypocretin-1-induced reinstatement and yo-
himbine-induced reinstatement can both be blocked by a
CRF-1 receptor antagonist (Boutrel et al. 2005;M a r i n e l l i
et al. 2007). In addition, yohimbine-induced increases in
ethanol operant self-administration are inhibited by antalar-
min, a CRF-1 receptor antagonist (Marinelli et al. 2007).
Furthermore, yohimbine-induced reinstatement of palatable
food seeking is reduced by inhibiting CRF-1 receptors
(Ghitza et al. 2006). Both yohimbine and CRF induce
release of noradrenaline in the locus coeruleus (Chen et al.
1992). Yohimbine has also been shown to up-regulate CRF
expression in the central nucleus of the amygdala (Funk et al.
2006), and there is evidence to suggest that the orexin/
hypocretin system can act through the amygdala to augment
arousal and evoke behavioral responses associated with fear,
stress, or emotion (Bisetti et al. 2006). We hypothesize that
yohimbine induces a stress-like response that leads to
activation of OX-1/Hcrt-1 receptors. Therefore, inhibiting
OX-1/Hcrt-1 receptors attenuates the stress-like response
leading to a reduction in yohimbine-induced reinstatement of
reward seeking as seen in the present study.
Methodological considerations
There are two main methodological considerations regarding
the present study. Firstly, it is possible that the observed
decrease in operant self-administration of ethanol and the
blockade of yohimbine-induced reinstatement were due to
motor deficits. Secondly, the attenuated yohimbine-induced
reinstatement of lever pressing could be due to nonspecific
decreases in general locomotor behavior. However, there was
no decrease in operant self-administration of sucrose after
administration of the highest does of SB334867. In addition,
Table 3 Effect of SB334867 on yohimbine-induced reinstatement
(inactive lever)
SB334867
(mg/kg i.p.)
10% Ethanol 5% Sucrose
Vehicle Yohimbine Vehicle Yohimbine
0 1±0 1±0 2±1 3±2
5 1±1 0±0 1±1 0±0
10 0±0 1±1 1±1 2±2
Mean±SEM number of inactive lever presses during extinction and
reinstatement tests. Extinction is shown as the average number of
lever presses across the two sessions preceding the first reinstatement
test for all rats. Rats were pretreated with SB334867 or its vehicle
30 min before yohimbine or its vehicle. Yohimbine (or vehicle) was
administered 30 min before the start of the reinstatement session (n=
8–11 per group for 10% ethanol; n=6–7, per group for 5% sucrose)
Psychopharmacology (2008) 199:109–117 115SB334867 had no effect on general locomotor activity in the
open field locomotor activity test. Therefore, the inhibitory
effect of SB334867 on ethanol self-administration and
yohimbine-induced reinstatement does not appear to be based
on reduced locomotor activity. Furthermore, in accordance
with previous studies (Ghitza et al. 2006;L ee ta l .2005;
Shepard et al. 2004), there was no increase in responding at
the inactive lever after the yohimbine injection in the
reinstatement experiment, suggesting that the effect of the
yohimbine treatment was specific to the active lever
previously associated with the reward of ethanol or sucrose,
respectively.
Conclusions
The results presented in the current study demonstrate that
OX-1/Hcrt-1 receptors are involved in mediating operant
self-administration of ethanol. These results support previ-
ous studies demonstrating a role for OX-1/Hcrt-1 receptors
in ethanol self-administration and olfactory-cue-induced
reinstatement (Lawrence et al. 2006). We further show that
inhibiting OX-1/Hcrt-1 receptors attenuates yohimbine-
induced reinstatement of both ethanol and sucrose seeking.
Our findings suggest that OX-1/Hcrt-1 receptors may
represent a possible target for the treatment of alcohol use
disorders.
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